Literature DB >> 1361351

HLA phenotype is a factor in determining rate of disease progression and outcome in HIV-1-infected individuals.

D L Mann1, M Carrington, M O'Donnell, T Miller, J Goedert.   

Abstract

HLA allele frequencies were examined for possible association(s) with the rate of disease progression and with the disease outcome (AIDS diagnosis) in a population of HIV-1-infected individuals. Certain alleles were associated with the relative rate of CD4+ T-cell decline. Association of particular alleles with several disease outcomes associated with infection was also observed. It is important to keep these two aspects (disease progression, AIDS diagnosis) separate when studying HLA in the HIV-1-infected population. Alleles that may play a role in the rate of virus speed by effecting the immune response may be different from those found to be associated with a particular disease. We feel that the only truly informative data, in this regard, can be generated from a relative precise determination of the time of infection (to study disease progression) and adequate numbers of individuals with specific diseases to study specific disease association. If such data can be generated we will have a much better understanding of the pathogenetic process(es) of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361351     DOI: 10.1089/aid.1992.8.1345

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Increased frequency of HLA-DR11 in pediatric human immunodeficiency virus-associated parotid gland enlargement.

Authors:  S J Schuval; M E O'Reilly; V R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

2.  Twin studies demonstrate a host cell genetic effect on productive human immunodeficiency virus infection of human monocytes and macrophages in vitro.

Authors:  J Chang; H M Naif; S Li; J S Sullivan; C M Randle; A L Cunningham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

Authors:  D R Henrard; S Wu; J Phillips; D Wiesner; J Phair
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro.

Authors:  A I Spira; D D Ho
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen.

Authors:  M J McElrath; L Corey; P D Greenberg; T J Matthews; D C Montefiori; L Rowen; L Hood; J I Mullins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.